1012886-75-7 Usage
Uses
Used in Pharmaceutical Industry:
4-(4-Fluorophenyl)-1-Methylis used as a research compound for understanding the mechanisms behind Parkinson's disease. Its application is crucial in the study of neurodegenerative diseases and the development of potential treatments.
Used in Neuroscience Research:
In neuroscience, 4-(4-Fluorophenyl)-1-Methylserves as a valuable tool for investigating the selective destruction of dopaminergic neurons and the subsequent effects on the brain. This helps researchers gain insights into the pathology of Parkinson's disease and other related conditions.
Used in Drug Development:
The compound is also utilized in the development of drugs targeting dopaminergic neurons. By studying the effects of 4-(4-Fluorophenyl)-1-Methylon these neurons, researchers can identify potential therapeutic agents that may help in the treatment or prevention of Parkinson's disease.
Used in Toxicology Studies:
4-(4-Fluorophenyl)-1-Methylis employed in toxicology research to evaluate the potential neurotoxic effects of various substances on dopaminergic neurons. This helps in understanding the risks associated with exposure to certain chemicals and the development of strategies to mitigate these risks.
Check Digit Verification of cas no
The CAS Registry Mumber 1012886-75-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,2,8,8 and 6 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1012886-75:
(9*1)+(8*0)+(7*1)+(6*2)+(5*8)+(4*8)+(3*6)+(2*7)+(1*5)=137
137 % 10 = 7
So 1012886-75-7 is a valid CAS Registry Number.
1012886-75-7Relevant articles and documents
Vesicular monoamine transporter substrate/inhibitor activity of MPTP/MPP+ derivatives: A structure-activity study
Wimalasena, D. Shyamali,Perera, Rohan P.,Heyen, Bruce J.,Balasooriya, Inoka S.,Wimalasena, Kandatege
, p. 760 - 768 (2008/09/19)
The active metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), N-methyl-4-phenylpyridinium (MPP+), selectively destroys the dopaminergic neurons and induces the symptoms of Parkinson's disease. Inhibition of mitochondrial complex